Wutah bathi EPS kuartalan cosciensbio.com (CSCI)

COSCIENS Biopharma Inc. relies on exclusive innovation rights and the global distribution of orphan drugs. The scaling model is based on licensing formulas for royalties without incurring plant costs. The company is currently expanding sales through oncology developments. The quarterly EPS growth efficiency metric demonstrates current profit dynamics, where -31.20 determines the current value of the indicator.

CSCI: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan COSCIENS Biopharma 10.08.2024 - 14.09.2025

COSCIENS Bio (CSCI) - rincian metrik lan laporan keuangan

- rega saham lan prakiraan rega para ahli:

Rega saham COSCIENS Biopharma|CSCI - Rata-rata rega prakiraan

- rincian kapitalisasi pasar:

Kapitalisasi pasar Aeterna Zentaris|CSCI - Nilai Bisnis

- indikator nilai aset resik miturut neraca:

Nilai Akuntansi saben Saham COSCIENS Biopharma|CSCI - Nilai Akuntansi Perusahaan|Rasio Nilai Pasar marang Nilai Buku cosciensbio.com|CSCI - Nilai Total Aset Perusahaan

- informasi babagan utang lan solvabilitas:

Total Utang marang Modal COSCIENS Biopharma Inc.|CSCI - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal COSCIENS Biopharma Inc.|CSCI - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Aeterna Zentaris|CSCI - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan COSCIENS Biopharma|Rasio cepet cosciensbio.com

- informasi bathi lan kelipatan valuasi:

CSCI - Bathi resik|Proyeksi bathi mangsa ngarep COSCIENS Biopharma Inc.|CSCI - Koefisien rega marang bathi|Rega marang bathi mangsa ngarep Aeterna Zentaris|CSCI - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Aeterna Zentaris|CSCI - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) COSCIENS Biopharma|CSCI - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan cosciensbio.com|CSCI - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep COSCIENS Biopharma Inc.

Analisis wiwitan perusahaan:COSCIENS Biopharma Inc.

This indicator measures the quarterly dynamics of earnings per share, allowing for the exclusion of one-time accounting adjustments to assess the actual efficiency of capital management. An analysis of the quarterly EPS growth for COSCIENS Biopharma Inc. (CSCI) reflects the extent to which the diversification of its orphan drug pipeline converts into financial results, confirming the long-term sustainability of the business model in the US and European markets.

Karo sapa COSCIENS Biopharma Inc. saingan